Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Terminated 3 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 1477 Neoplasms 999 Colorectal Neoplasms 832 Carcinoma, Non-Small-Cell Lung 724 Carcinoma, Hepatocellular 683 Stomach Neoplasms 648 Lung Neoplasms 584 Prostatic Neoplasms 543 Pancreatic Neoplasms 456 Rectal Neoplasms 339 Uterine Cervical Neoplasms 303 Colonic Neoplasms 295 Neoplasm Metastasis 294 Ovarian Neoplasms 285 Esophageal Neoplasms 279 Recurrence 278 Leukemia, Myeloid, Acute 253 Head and Neck Neoplasms 241 Multiple Myeloma 232 Brain Neoplasms 204 Polycystic Ovary Syndrome 200 Nasopharyngeal Carcinoma 198 Melanoma 198 Precursor Cell Lymphoblastic Leukemia-Lymphoma 195 Urinary Bladder Neoplasms 193 Lymphoma 178 Liver Neoplasms 178 Endometrial Neoplasms 159 Motor Activity 147 Lymphoma, Large B-Cell, Diffuse 141

Interventions

enzalutamide 1 capivasertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × Adenocarcinoma of the Prostate × Clear all

NCT02525068 2018-08-08

RE-AKT

Institute of Cancer Research, United Kingdom

Phase 2 Unknown

Adenocarcinoma of the Prostate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡